1. Home
  2. LEXX vs MGRX Comparison

LEXX vs MGRX Comparison

Compare LEXX & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.70

Market Cap

16.3M

Sector

Health Care

ML Signal

HOLD

Logo Mangoceuticals Inc.

MGRX

Mangoceuticals Inc.

HOLD

Current Price

$0.89

Market Cap

15.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEXX
MGRX
Founded
2004
2021
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
16.3M
15.6M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
LEXX
MGRX
Price
$0.70
$0.89
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
01-13-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$705,923.00
$466,908.00
Revenue This Year
$13.35
N/A
Revenue Next Year
$78.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
52.05
N/A
52 Week Low
$0.46
$0.52
52 Week High
$2.43
$6.15

Technical Indicators

Market Signals
Indicator
LEXX
MGRX
Relative Strength Index (RSI) 43.39 43.36
Support Level $0.46 $0.65
Resistance Level $0.72 $0.90
Average True Range (ATR) 0.10 0.14
MACD 0.01 0.03
Stochastic Oscillator 58.20 39.44

Price Performance

Historical Comparison
LEXX
MGRX

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: